List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 30 studies with search of: IgA nephropathy
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy
Condition: IGA Nephropathy
Intervention: Drug: Mycophenolate mofetil
2 Completed Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
Condition: IGA Nephropathy
Intervention: Drug: ENALAPRIL VALSARTAN METHYLPREDNISONE
3 Recruiting A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Conditions: Glomerulonephritis;   IGA Nephropathy：a Kind of Glomerulonephritis,Which IgA is the Dorminant Immunodeposit in Mesangial Areas
Interventions: Drug: Valsartan;   Drug: Probucol;   Drug: Placebo
4 Recruiting Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy
Condition: Glomerulonephritis, IGA
Intervention: Procedure: gene transcription and cytometry
5 Active, not recruiting Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
Conditions: Glomerulonephritis, IGA;   Nephropathy, IGA;   IGA Nephropathy
Interventions: Drug: sirolimus + ACE inhibitor + statin;   Drug: ACE inhibitor + statin
6 Recruiting A Controlled Study of Uric Acid on the Progression of IgA Nephropathy
Condition: IGA Nephropathy
Interventions: Drug: allopurinol;   Other: usual therapy
7 Recruiting Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy
Conditions: IGA Nephropathy;   Proteinuria
Intervention: Biological: OPL-CCL2-LPM
8 Recruiting Rituximab in Progressive IgA Nephropathy
Condition: IGA Nephropathy
Interventions: Drug: Intravenous Rituximab;   Drug: Group 2 ACE/ARB
9 Recruiting Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
Condition: IGA Nephropathy
Intervention: Drug: Mycophenolate Mofetil
10 Recruiting Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)
Condition: IGA Nephropathy
Interventions: Drug: irbesartan;   Drug: methylprednisolone (MP) or prednisone (pred);   Drug: mycophenolate mofetil (MMF)
11 Active, not recruiting Study to Evaluate the Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of IgA Nephropathy
Condition: IGA Nephropathy
Intervention: Drug: Omega-3 fatty acid ethylester90
12 Completed Mycophenolate Mofetil for IgA Nephropathy
Condition: IGA Nephropathy
Interventions: Drug: mycophenolate mofetil;   Drug: angiotensin blockade
13 Completed Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study
Condition: IGA Nephropathy
Intervention: Drug: Budesonide
14 Withdrawn Paricalcitol for the Treatment of Immunoglobulin A Nephropathy
Condition: IGA Nephropathy
Intervention: Drug: paricalcitol
15 Completed "Steroids and Azathioprine Versus Steroids Alone in IgAN"
Condition: IGA Nephropathy
Interventions: Drug: steroids plus azathioprine;   Drug: steroids
16 Recruiting Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
Condition: IGA Nephropathy
Interventions: Drug: supportive therapy with: ACE-inhibitor / ARB / Statin;   Drug: supportive and immunosuppressive therapy
17 Completed Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy
Condition: IGA Glomerulonephritis
Intervention: Drug: enalapril
18 Completed Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy
Condition: IGA Nephropathy
Intervention: Drug: Calcitriol
19 Not yet recruiting Aliskiren for Immunoglobulin A (IgA) Nephropathy
Condition: IGA Nephropathy
Interventions: Drug: Aliskiren;   Drug: Placebo
20 Recruiting Prospective Study of Tripterygium Wilfordii (TW) in Treatment of IgA Nephropathy (IgAN) With Asymptomatic Abnormal Urinalysis
Condition: IGA Nephropathy
Intervention: Drug: tripterygium wilfordii (TW)

Previous Page Studies Shown (1-20) Next Page (21-30)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services